Journey Medical Corporation
US ˙ NasdaqCM ˙ US48115J1097

SecurityDERM / Journey Medical Corporation
InstitutionState Street Corp
Latest Disclosed Ownership237,288 shares
Latest Disclosed Value $ 1,112,881
State Street Corp reports 36.89% increase in ownership of DERM / Journey Medical Corporation

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 237,288 shares of Journey Medical Corporation (US:DERM) valued at $1,112,881 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 173,337 shares of Journey Medical Corporation. This represents a change in shares of 36.89% during the quarter. The current value of the position is $1,475,931 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F JOURNEY MED COM 48115J109 237,288 63,951 36.89 1,113 -16.77 0.0000
2026-02-13 2025-12-31 13F JOURNEY MED COM 48115J109 173,337 27,300 18.69 1,336 28.59 0.0000
2025-11-14 2025-09-30 13F JOURNEY MED COM 48115J109 146,037 31,061 27.02 1,040 25.94 0.0000
2025-08-14 2025-06-30 13F JOURNEY MED COM 48115J109 114,976 86,023 297.11 826 385.29 0.0000
2025-05-15 2025-03-31 13F JOURNEY MED COM 48115J109 28,953 0 0.00 171 50.44 0.0000
2025-02-14 2024-12-31 13F JOURNEY MED COM 48115J109 28,953 3,400 13.31 113 -21.53 0.0000
2024-11-14 2024-09-30 13F JOURNEY MED COM 48115J109 25,553 0 0.00 144 0.00 0.0000
2024-08-14 2024-06-30 13F JOURNEY MED COM 48115J109 25,553 0 0.00 144 53.19 0.0000
2024-05-15 2024-03-31 13F JOURNEY MED COM 48115J109 25,553 0 0.00 94 -36.05 0.0000
2024-02-14 2023-12-31 13F JOURNEY MED COM 48115J109 25,553 13,700 115.58 147 359.38 0.0000
2023-11-14 2023-09-30 13F JOURNEY MED COM 48115J109 11,853 11,853 32 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.